Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Towards resolving the enigma of the dichotomy of resveratrol: cis- and trans-resveratrol have opposite effects on TyrRS-regulated PARP1 activation

GeroScience(2020)10.1007/s11357-020-00295-wSource: DataRank Database

Towards resolving the enigma of the dichotomy of resveratrol: cis- and trans-resveratrol have opposite effects on TyrRS-regulated PARP1 activation is a research paper published in GeroScience (2020). On theSindex it has a DataRank of 0. It has been cited 35 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access35 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 2.43)OA: greenTopics (33)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (3)

C.N.R. Rao ORCID,Mathew Sajish ORCID,Megha Jhanji ORCID

Live enrichment

PubMed:33244652 PMC:PMC7690980 OpenAlex:https://openalex.org/W3107517055

National Institute of General Medical Sciences

Grant: 2P20GM109091-06

Center for Targeted Therapeutics

NIGMS NIH HHS

Grant: P20 GM109091

National Science Foundation

Grant: 1755670

CSBR: Living Stocks Support for the Peromyscus Genetic Stock Center

FWCI

2.43

Citation Percentile

0.9%

Citation Trend

2021

2022

2023

2024

2025

2026

greenLicense: Springer Nature TDM

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/7690980

publisherhttps://link.springer.com/content/pdf/10.1007/s11357-020-00295-w.pdf

publisherhttps://link.springer.com/article/10.1007/s11357-020-00295-w/fulltext.html

journalhttps://doi.org/10.1007/s11357-020-00295-w

Fields of Study

Sirtuins and Resveratrol in MedicinePARP inhibition in cancer therapyCalcium signaling and nucleotide metabolism0301 basic medicine0303 health sciences03 medical and health sciences

MeSH Terms

Poly (ADP-Ribose) Polymerase-1ResveratrolAnimalsDNA DamageHumansTyrosine-tRNA Ligase

Keywords

ResveratrolContext (archaeology)TyrosineBiologyChemistryBiochemistryAmp-activated Protein Kinase (Ampk)Resveratrol (Rsv)Nicotinamide (Nam)Poly-adp-ribose Polymerase (Parp)Aminoacyl-trna Synthetases (Aarss)Nicotinamide Adenine Nucleotide (Nad+)Sirtuins (Sirt)Tyrrs)Tyrosyl-trna Synthetase (YarsTyrosine-tRNA LigasePoly (ADP-Ribose) Polymerase-1AnimalsHumansOriginal ArticleDNA Damage

Sustainable Development Goals

SDG 0: Responsible consumption and production

Towards resolving the enigma of the dichotomy of resveratrol: cis- and trans-resveratrol have opposite effects on TyrRS-regulated PARP1 activation

FAIR Checklist

Authors (3)

Funding (3 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)